Skip to main content
OpenTrials

Clinical trial condition

Primary Myelofibrosis

Explore clinical trials studying Primary Myelofibrosis. Study availability and eligibility vary by location and protocol.

457 public trials 86 recruiting studies
Refine in advanced search Browse all conditions

Primary Myelofibrosis trial results

Recruiting

A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant

NCT07020533

Conditions
Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +38 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Northside Hospital Atlanta, Georgia, United States
  • Brigham and Women's Hospital Boston, Massachusetts, United States
View Trial Details
Recruiting

Pacritinib For Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia

NCT07394153

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Hospital del Mar Barcelona Barcelona, Spain
  • Hospital Universitario Vall d´Hebron Barcelona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Hospital Universitario de Jerez Jerez de la Frontera, Cádiz, Spain
View all 13 locations
View Trial Details
Recruiting

Study of INCA036978 in Participants With Myeloproliferative Neoplasms

NCT07441694

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • University of Alabama At Birmingham Birmingham, Alabama, United States
  • City of Hope-Lennar Foundation Cancer Center Irvine, California, United States
  • Usc Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UCLA Medical Hematology & Oncology Los Angeles, California, United States
View all 54 locations
View Trial Details
Recruiting

A Clinical Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of TQ05105 Tablets in Subjects With Intermediate/High-risk Myelofibrosis

NCT07551427

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Guangzhou First Municipal People's Hospital Guangzhou, Guangdong, China
  • The First Affiliated Hospital of Guangxi Medical University Nanning, Guangxi, China
View all 24 locations
View Trial Details
Recruiting

Clinical Epidemiology in Contemporary Patients With Myelofibrosis.

NCT06533813

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations
  • Hematology Center after Prof.R.H. Yeolyan Yerevan, Armenia
  • University Hospital Halle Department of Hematology/Oncology Halle, Germany
  • University Medicine Hannover Hanover, Germany
  • University Clinic for Hematology, Oncology, Hemostaseology and Palliative Care Johannes Wesling Medical Center Minden UKRUB, University of Bochum Minden, Germany
View all 27 locations
View Trial Details
Recruiting

Registry of Older Patients With Cancer

NCT01137825

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +98 more
Locations
  • Seby B. Jones Cancer Center Boone, North Carolina, United States
  • Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States
  • East Carolina University Greenville, North Carolina, United States
  • Pardee Cancer Center Hendersonville, North Carolina, United States
View Trial Details

Related conditions